Harel Insurance Investments & Financial Services’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40K | Buy |
+26,000
| New | +$40K | ﹤0.01% | 362 |
|
|
2017
Q4 | – | Sell |
-2,000
| Closed | -$12K | – | 496 |
|
|
2017
Q3 | $12K | Hold |
2,000
| – | – | ﹤0.01% | 387 |
|
|
2017
Q2 | $17K | Sell |
2,000
-335
| -14% | -$2.85K | ﹤0.01% | 360 |
|
|
2017
Q1 | $25K | Sell |
2,335
-1,665
| -42% | -$17.8K | ﹤0.01% | 302 |
|
|
2016
Q4 | $18K | Hold |
4,000
| – | – | ﹤0.01% | 260 |
|
|
2016
Q3 | $23K | Buy |
+4,000
| New | +$23K | ﹤0.01% | 294 |
|